Trial Profile
Optimization of Humira
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 03 Oct 2021
Price :
$35
*
At a glance
- Drugs Adalimumab (Primary)
- Indications Rheumatoid arthritis
- Focus Therapeutic Use
- Acronyms OH
- 27 Apr 2012 New source identified and integrated (ClinicalTrials.gov record NCT01585064).
- 16 Jun 2010 Results have been reported at EULAR 2010.
- 10 Jun 2009 New trial record